Pharmaceutical aspects. Nasal and depot formulations of leuprolide.
D000281:Administration, Intranasal; D000818:Animals; D001682:Biological Availability; D003692:Delayed-Action Preparations; D004285:Dogs; D004333:Drug Administration Routes; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007275:Injections, Intravenous; D016729:Leuprolide; D008297:Male; D008863:Microspheres; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy; D051381:Rats; D013739:Testosterone / Q000097:blood
D003692:Delayed-Action Preparations; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D016729:Leuprolide